If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
<br /> 3. SEGMENT INFORMATION CONTINUED<br /> (b) Segment information continued<br /> Cardiovascular<br /> Orthopedic & non-orthopedic Total<br /> $$$<br /> Parent<br /> 30 June 2010<br /> Revenue from external parties 5,500 - 5,500<br /> Total segment revenue 5,500 - 5,500<br /> Net (loss) after tax (6,827,114) (4,394,047) (11,221,161)<br /> Net loss after tax includes the following items:<br /> Research and development 6,788,883 - 6,788,883<br />
Annual Report 2011
Annual Report 2011
Contents
Contents
Message from theChairmanThe Mesoblast Board o
Message from theChairmanThe Mesoblast Board o
Chief Executive’s ReportI am delighted to repor
Chief Executive’s ReportI am delighted to repor
Strategic AlliancesIn December 2010 we entered i
Strategic AlliancesIn December 2010 we entered i
Orthopedic ProgramsMesoblast is developing innov
Orthopedic ProgramsMesoblast is developing innov
Eye Disease ProgramsOur lead ophthalmic indicati
Eye Disease ProgramsOur lead ophthalmic indicati
Directors’ ReportThe Board of Directors of Meso
Directors’ ReportThe Board of Directors of Meso
Principal Activities & StrategyReview of Operat
Principal Activities & StrategyReview of Operat
In July, Cephalon stockholders voted to approvea
In July, Cephalon stockholders voted to approvea
Fraction less than 40%, a population that histori
Fraction less than 40%, a population that histori
Global RecognitionIn March, Chief Executive Silv
Global RecognitionIn March, Chief Executive Silv
ExpenditureIn line with the Group's policy and t
ExpenditureIn line with the Group's policy and t
The balances arising on acquisition, at their fai
The balances arising on acquisition, at their fai
Share OptionsShares under optionUnissued ordina
Share OptionsShares under optionUnissued ordina
Shares issued on exercise of optionsDetail of sh
Shares issued on exercise of optionsDetail of sh
Environmental RegulationsThe Board considers tha
Environmental RegulationsThe Board considers tha
Information on DirectorsBrian Jamieson, Non
Information on DirectorsBrian Jamieson, Non
Michael Spooner, Non-executive Director BCoM, ACA
Michael Spooner, Non-executive Director BCoM, ACA
Meetings of DirectorsThe number of meetings of t
Meetings of DirectorsThe number of meetings of t
A. Remuneration Principles and PoliciesBoard po
A. Remuneration Principles and PoliciesBoard po
(b) Executive payThe executive pay and reward fr
(b) Executive payThe executive pay and reward fr
The share price increase from 2010 to 2011 is att
The share price increase from 2010 to 2011 is att
Remuneration detailsDetails of the remuneration
Remuneration detailsDetails of the remuneration
Post-employment Share-basedbenefits
Post-employment Share-basedbenefits
The relative proportions of remuneration that are
The relative proportions of remuneration that are
C. Share-Based CompensationOptions to purchase
C. Share-Based CompensationOptions to purchase
All share options issued to key management person
All share options issued to key management person
Value of options held by key management personnel
Value of options held by key management personnel
Value of options yet to vest after the end of the
Value of options yet to vest after the end of the
Auditor!s Independence DeclarationAs
Auditor!s Independence DeclarationAs
Corporate GovernanceMesoblast Limited (the Comp
Corporate GovernanceMesoblast Limited (the Comp
The term in office held by each director in office
The term in office held by each director in office
2.4 Board committeesThe following committees hav
2.4 Board committeesThe following committees hav
Principle 3. Promote ethical and responsibledeci
Principle 3. Promote ethical and responsibledeci
4.3 Formal charterThe audit and risk committee o
4.3 Formal charterThe audit and risk committee o
Principle 7. Recognize and manage risk7.1 Estab
Principle 7. Recognize and manage risk7.1 Estab
Financial Statementsfor the year ended 30 June 2
Financial Statementsfor the year ended 30 June 2
Consolidated Income Statementfor the year ended
Consolidated Income Statementfor the year ended
Consolidated Statement ofComprehensive Incomefo
Consolidated Statement ofComprehensive Incomefo
Consolidated Statement ofChanges in Equityfor t
Consolidated Statement ofChanges in Equityfor t
Consolidated Balance Sheetas at 30 June 2011
Consolidated Balance Sheetas at 30 June 2011
Consolidated Statement of Cash Flowsfor the year
Consolidated Statement of Cash Flowsfor the year
Notes to the Financial Statementsfor the year en
Notes to the Financial Statementsfor the year en
1. SIGNIFICANT ACCOUNTING POLICIESStatement of
1. SIGNIFICANT ACCOUNTING POLICIESStatement of
1. SIGNIFICANT ACCOUNTING POLICIES CONTINUEDNew
1. SIGNIFICANT ACCOUNTING POLICIES CONTINUEDNew
1. SIGNIFICANT ACCOUNTING POLICIES CONTINUED(b)
1. SIGNIFICANT ACCOUNTING POLICIES CONTINUED(b)
1. SIGNIFICANT ACCOUNTING POLICIES CONTINUED(d)
1. SIGNIFICANT ACCOUNTING POLICIES CONTINUED(d)
1. SIGNIFICANT ACCOUNTING POLICIES CONTINUED(f)
1. SIGNIFICANT ACCOUNTING POLICIES CONTINUED(f)
1. SIGNIFICANT ACCOUNTING POLICIES CONTINUEDThe
1. SIGNIFICANT ACCOUNTING POLICIES CONTINUEDThe
1. SIGNIFICANT ACCOUNTING POLICIES CONTINUEDThe
1. SIGNIFICANT ACCOUNTING POLICIES CONTINUEDThe
1. SIGNIFICANT ACCOUNTING POLICIES CONTINUED(q)
1. SIGNIFICANT ACCOUNTING POLICIES CONTINUED(q)
1. SIGNIFICANT ACCOUNTING POLICIES CONTINUED(u)
1. SIGNIFICANT ACCOUNTING POLICIES CONTINUED(u)
1. SIGNIFICANT ACCOUNTING POLICIES CONTINUED
1. SIGNIFICANT ACCOUNTING POLICIES CONTINUED
30 June 2011 30 June 2010$$2. REVENUE
30 June 2011 30 June 2010$$2. REVENUE
3. SEGMENT INFORMATION(a) Description of segment
3. SEGMENT INFORMATION(a) Description of segment
3. SEGMENT INFORMATION CONTINUED(b) Segment info
3. SEGMENT INFORMATION CONTINUED(b) Segment info
3. SEGMENT INFORMATION CONTINUED(c) Segment rec
3. SEGMENT INFORMATION CONTINUED(c) Segment rec
Consolidated Parent30 June 20
Consolidated Parent30 June 20
5. REMUNERATION OF AUDITORS(a) PricewaterhouseCo
5. REMUNERATION OF AUDITORS(a) PricewaterhouseCo
9. PROPERTY, PLANT AND EQUIPMENTTotal^At 1 July
9. PROPERTY, PLANT AND EQUIPMENTTotal^At 1 July
10. DEFERRED TAX ASSETS
10. DEFERRED TAX ASSETS
11. INVESTMENTS ACCOUNTED FOR USING THE EQUITY ME
11. INVESTMENTS ACCOUNTED FOR USING THE EQUITY ME
12. INTANGIBLE ASSETS
12. INTANGIBLE ASSETS
Consolidated Parent
Consolidated Parent
Consolidated Parent
Consolidated Parent
17. ISSUED CAPITAL CONTINUED(b) Movements in ord
17. ISSUED CAPITAL CONTINUED(b) Movements in ord
17. ISSUED CAPITAL ConTInUED(c) ordinary shares
17. ISSUED CAPITAL ConTInUED(c) ordinary shares
18. RESERVES CONTINUED(c) Nature and purpose of
18. RESERVES CONTINUED(c) Nature and purpose of
20. BUSINESS COMBINATIONDuring the reporting ye
20. BUSINESS COMBINATIONDuring the reporting ye
Parent Parent30 June
Parent Parent30 June
24. SHARE-BASED PAYMENTSThe Group has adopted a
24. SHARE-BASED PAYMENTSThe Group has adopted a
24. SHARE-BASED PAYMENTS coNTiNuED(i) The follo
24. SHARE-BASED PAYMENTS coNTiNuED(i) The follo
24. SHARE-BASED PAYMENTS CONTINUED(b) Existing
24. SHARE-BASED PAYMENTS CONTINUED(b) Existing
24. SHARE-BASED PAYMENTS CONTINUED(c) Fair valu
24. SHARE-BASED PAYMENTS CONTINUED(c) Fair valu
24. SHARE-BASED PAYMENTS CONTINUED(d) Share opt
24. SHARE-BASED PAYMENTS CONTINUED(d) Share opt
24. SHARE-BASED PAYMENTS CONTINUED(d) Share opt
24. SHARE-BASED PAYMENTS CONTINUED(d) Share opt
25. KEY MANAGEMENT PERSONNEL CONTINUED(b) Key m
25. KEY MANAGEMENT PERSONNEL CONTINUED(b) Key m
25. KEY MANAGEMENT PERSONNEL CONTINUED(c) Key m
25. KEY MANAGEMENT PERSONNEL CONTINUED(c) Key m
26. RELATED PARTY TRANSACTIONS(a) Parent entity
26. RELATED PARTY TRANSACTIONS(a) Parent entity
Consolidated Parent
Consolidated Parent
Consolidated Parent
Consolidated Parent
27. FINANCIAL RISK MANAGEMENTFinancial risks im
27. FINANCIAL RISK MANAGEMENTFinancial risks im
27. FINANCIAL RISK MANAGEMENT CoNTINuEd(a) Marke
27. FINANCIAL RISK MANAGEMENT CoNTINuEd(a) Marke
27. FINANCIAL RISK MANAGEMENT CONTINUED(b) Cred
27. FINANCIAL RISK MANAGEMENT CONTINUED(b) Cred
Directors’ DeclarationIn accordance wit
Directors’ DeclarationIn accordance wit
87
87
88
88
Shareholder InformationA. SUBSTANTIAL S
Shareholder InformationA. SUBSTANTIAL S
Shareholder InformationcontinuedD. TWENTY
Shareholder InformationcontinuedD. TWENTY
Mesoblast Limited ABN 68 109 431 870Board of Dir
Mesoblast Limited ABN 68 109 431 870Board of Dir
92
92